focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Goldman Cuts RBS To Neutral From Buy

Tue, 12th Nov 2013 10:18

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
NOMURA DOWNGRADES BRITISH SKY BROADCASTING GROUP PLC (BSY.L) TO REDUCE FROM BUY
----------
S&P CAPITAL IQ CUTS BSKYB TO 'SELL' ('BUY') - PRICE TARGET 700 (1050) PENCE
----------
CREDIT SUISSE CUTS BSKYB TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 700 (810) PENCE
----------
UBS RAISES SMITHS GROUP PRICE TARGET TO 1000 (750) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RBS TO 'NEUTRAL' ('BUY') - TARGET 370 (400) PENCE
----------
NOMURA RAISES RBS PRICE TARGET TO 285 (270) PENCE - 'REDUCE'
----------
MACQUARIE REMOVES RBS FROM 'CONVICTION SELL LIST'
----------
JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 126 (140) P.
----------
NOMURA CUTS RSA INSURANCE PRICE TARGET TO 113 (120) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ITV TO 'NEUTRAL' ('BUY') - TARGET 191 (180) PENCE
----------
PANMURE CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY') - TARGET 1,750 (1,850) PENCE
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3615 (3270) PENCE - 'BUY'
----------
MACQUARIE REMOVES IAG FROM 'CONVICTION BUY LIST' - 'OUTPERFORM'
----------
MORGAN STANLEY RAISES ROLLS-ROYCE PRICE TARGET TO 1400 (1300) P. - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS CUTS BALFOUR BEATTY TO 'SELL' ('NEUTRAL') - TARGET 245 (220) PENCE
----------
UBS CUTS COBHAM PRICE TARGET TO 290 (305) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 270 (275) PENCE - 'HOLD'
----------
BARCLAYS INITIATES F&C ASSET MANAGEMENT WITH 'UNDERWEIGHT' - TARGET 90 PENCE
----------
CITIGROUP RAISES LONMIN PRICE TARGET TO 453 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LONMIN PRICE TARGET TO 390 (315) PENCE - 'HOLD'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 430 (400) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LONMIN PRICE TARGET TO 512 (485) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HALFORDS GROUP PRICE TARGET TO 410 (330) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES WH SMITH PLC PRICE TARGET TO 1075 (960) PENCE - 'BUY'
----------
EXANE BNP RAISES SHAFTESBURY TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 580 PENCE
----------
NUMIS CUTS MENZIES(JOHN) TO 'HOLD' ('ADD') - TARGET 774 (834) PENCE
----------
PANMURE RAISES BTG PRICE TARGET TO 490 (450) PENCE - 'BUY'
----------
PANMURE RAISES RIGHTMOVE PRICE TARGET TO 3,130 (3,000) PENCE - 'BUY'
----------
CANACCORD RAISES CATLIN GROUP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
NUMIS RAISES CATLIN GROUP TO 'HOLD' ('REDUCE') - TARGET 575 (420) PENCE
----------
JEFFERIES CUTS MORGAN ADVANCED MATERIALS PRICE TARGET TO 340 (345) PENCE- 'BUY'
----------
JEFFERIES RAISES RENTOKIL INITIAL PRICE TARGET TO 116 (104) PENCE - 'HOLD'
----------
NUMIS CUTS DIGNITY TO 'HOLD' ('ADD') - TARGET 1,575 (1,625) PENCE
----------
Numis Upgrades Oxford Instruments To Buy From Add, Price Target 1,600p
----------
ALL-SHARE AND AIM
----------
GOLDMAN RAISES SHANKS GROUP PRICE TARGET TO 128 (126) PENCE - 'BUY'
----------
CANACCORD CUTS CHESNARA PLC TO 'HOLD' ('BUY') - TARGET 300 (290) PENCE
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.